Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $669.29 billion, total revenue of $165.59 billion and a weighted average PE ratio of 38.06.
Market Cap
669.29B
Revenue
165.59B
Profits
17.58B
PE Ratio
38.06
Profit Margin
10.62%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 185.98B | -0.60% | 1,490,722 | 44.56B |
| 2 | DHR | Danaher Corporation | 136.58B | -1.63% | 2,902,594 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 46.56B | -1.20% | 448,093 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.61B | -1.31% | 1,218,693 | 7.07B |
| 5 | WAT | Waters Corporation | 31.16B | -0.28% | 883,434 | 3.17B |
| 6 | NTRA | Natera, Inc. | 28.77B | -3.71% | 1,490,502 | 2.31B |
| 7 | IQV | IQVIA Holdings Inc. | 28.37B | -2.06% | 1,912,637 | 16.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 27.03B | 0.93% | 158,703 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 22.52B | -0.53% | 454,262 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.90B | -0.50% | 718,335 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 18.91B | -3.38% | 2,307,092 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 14.32B | -3.68% | 364,394 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 11.43B | -6.11% | 1,815,323 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 10.11B | 0.07% | 1,095,684 | 2.86B |
| 15 | CRL | Charles River Laboratories International, Inc. | 8.64B | 0.27% | 839,125 | 4.02B |
| 16 | QGEN | Qiagen N.V. | 8.48B | -0.63% | 1,113,974 | 2.09B |
| 17 | ICLR | ICON Public Limited Company | 8.15B | 0.17% | 692,962 | 8.10B |
| 18 | RDNT | RadNet, Inc. | 4.35B | 0.29% | 620,416 | 2.04B |
| 19 | SHC | Sotera Health Company | 4.35B | 0.26% | 1,858,694 | 1.16B |
| 20 | BLLN | BillionToOne, Inc. | 3.79B | -10.31% | 446,550 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 2.99B | -4.55% | 736,416 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.49B | -4.04% | 510,404 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 1.95B | -6.34% | 908,651 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.76B | -8.45% | 999,805 | 427.54M |
| 25 | NEO | NeoGenomics, Inc. | 1.03B | -3.41% | 1,124,192 | 727.33M |
| 26 | OPK | OPKO Health, Inc. | 888.11M | -1.68% | 1,440,544 | 606.88M |
| 27 | CDNA | CareDx, Inc. | 854.80M | -6.86% | 871,514 | 379.81M |
| 28 | CSTL | Castle Biosciences, Inc. | 696.60M | -6.99% | 216,126 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 637.49M | -3.79% | 1,656,761 | 69.65M |
| 30 | FLGT | Fulgent Genetics, Inc. | 433.25M | -5.12% | 415,878 | 322.67M |
| 31 | MYGN | Myriad Genetics, Inc. | 415.18M | -6.92% | 1,415,297 | 824.50M |
| 32 | PRE | Prenetics Global Limited | 293.99M | -11.54% | 217,641 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 174.96M | 0.06% | 14,256 | 77.14M |
| 34 | BDSX | Biodesix, Inc. | 131.31M | -6.53% | 62,519 | 88.50M |
| 35 | FONR | FONAR Corporation | 122.00M | -0.05% | 6,733 | 106.03M |
| 36 | MDXH | MDxHealth SA | 106.32M | 0.98% | 278,254 | 107.88M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 102.29M | 5.30% | 537,045 | 4.06M |
| 38 | XGN | Exagen Inc. | 74.32M | 0.32% | 245,673 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 49.62M | -0.29% | 9,432 | 24.05M |
| 40 | BIAF | bioAffinity Technologies, Inc. | 14.92M | -15.31% | 974,805 | 6.16M |
| 41 | MBAI | Check-Cap Ltd. | 12.03M | 0.61% | 64,837 | - |
| 42 | XWEL | XWELL, Inc. | 9.75M | -6.11% | 210,716 | 29.21M |
| 43 | ADVB | Advanced Biomed Inc. | 9.13M | 5.52% | 79,113 | - |
| 44 | NOTV | Inotiv, Inc. | 7.93M | -9.07% | 352,744 | 514.03M |
| 45 | NDRA | ENDRA Life Sciences Inc. | 6.59M | 2.71% | 8,965 | - |
| 46 | QUCY | Mainz Biomed N.V. | 5.93M | -7.06% | 555,560 | 537.08K |
| 47 | ISPC | iSpecimen Inc. | 3.86M | -10.34% | 66,880,074 | 1.93M |